Additional information
Yellow Powder
151110-15-5
ACI-020806
191.6-194.8°C
C11H8BrN5
290.12
Ambient
2-8°C
ocular hypertension
Pharmaceutical Impurity Standards
5-Bromo-N-(1H-imidazol-2-yl)quinoxalin-6-amine
5-Bromo-N-1H-imidazol-2-yl-6-quinoxalinamine
4,5-Didehydro Brimonidine





![sec-BUTYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(2S)-2-methyl-1-oxobutyl]amino]benzenepropanoate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)